Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study).
Ishii M, Hirai I, Tanese K, Fusumae T, Nakamura Y, Fukuda K, Uchi H, Kabashima K, Otsuka A, Yokota K, Yamazaki N, Namikawa K, Fujimura T, Takenouchi T, Yamamoto Y, Nishiguchi M, Sato Y, Amagai M, Funakoshi T.
Ishii M, et al. Among authors: nishiguchi m.
Medicine (Baltimore). 2020 Oct 30;99(44):e22913. doi: 10.1097/MD.0000000000022913.
Medicine (Baltimore). 2020.
PMID: 33126349
Free PMC article.